Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › Arizona
Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in Arizona
6 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in Arizona.
Cities in Arizona
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Site Number - 1612, Tucson
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07032662A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
- Banner University of Arizona Medical Center, Tucson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07091630A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
- Banner University of Arizona Medical Center, Tucson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06920004A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Clinical Study Site, Phoenix
- Clinical Study Site, Scottsdale
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 28, 2026 · NCT06858579A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- HonorHealth Bob Bove Neuroscience Institute - Site Number : 8400014, Scottsdale
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT06290141A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- HonorHealth Neurology, Scottsdale
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jan 20, 2026 · NCT06747351From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.